441 related articles for article (PubMed ID: 12757160)
1. Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients.
Gonlachanvit S; Hsu CW; Boden GH; Knight LC; Maurer AH; Fisher RS; Parkman HP
Dig Dis Sci; 2003 Mar; 48(3):488-97. PubMed ID: 12757160
[TBL] [Abstract][Full Text] [Related]
2. Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects.
Becker RH; Stechl J; Steinstraesser A; Golor G; Pellissier F
Diabetes Metab Res Rev; 2015 Sep; 31(6):610-8. PubMed ID: 25773712
[TBL] [Abstract][Full Text] [Related]
3. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
Meier JJ; Kemmeries G; Holst JJ; Nauck MA
Diabetes; 2005 Jul; 54(7):2212-8. PubMed ID: 15983224
[TBL] [Abstract][Full Text] [Related]
4. Induced-hyperglycemia attenuates erythromycin-induced acceleration of hypertonic liquid-phase gastric emptying in type-I diabetic patients.
Petrakis IE; Chalkiadakis G; Vrachassotakis N; Sciacca V; Vassilakis SJ; Xynos E
Dig Dis; 1999; 17(4):241-7. PubMed ID: 10754365
[TBL] [Abstract][Full Text] [Related]
5. The impact of soluble dietary fibre on gastric emptying, postprandial blood glucose and insulin in patients with type 2 diabetes.
Yu K; Ke MY; Li WH; Zhang SQ; Fang XC
Asia Pac J Clin Nutr; 2014; 23(2):210-8. PubMed ID: 24901089
[TBL] [Abstract][Full Text] [Related]
6. Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes.
Ozaki K; Monnai M; Onoma M; Muramatsu H; Yogo K; Watanabe T; Oda Y; Katagiri K; Arakawa H; Itoh Z; Omura S; Takanashi H
J Diabetes Complications; 2008; 22(5):339-47. PubMed ID: 18413164
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in healthy subjects.
Petrakis IE; Kogerakis N; Vrachassotakis N; Stiakakis I; Zacharioudakis G; Chalkiadakis G
Abdom Imaging; 2002; 27(3):309-14. PubMed ID: 12173362
[TBL] [Abstract][Full Text] [Related]
8. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
[TBL] [Abstract][Full Text] [Related]
9. Erythromycin enhances solid-phase gastric emptying in induced-hyperglycemia in patients with truncal vagotomy and pyloroplasty.
Petrakis IE; Vrachassotakis N; Vassilakis SJ; Sciacca V; Chalkiadakis G
Dig Dis Sci; 2000 May; 45(5):937-45. PubMed ID: 10795758
[TBL] [Abstract][Full Text] [Related]
10. Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity.
Hjerpsted JB; Flint A; Brooks A; Axelsen MB; Kvist T; Blundell J
Diabetes Obes Metab; 2018 Mar; 20(3):610-619. PubMed ID: 28941314
[TBL] [Abstract][Full Text] [Related]
11. Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects.
Jones KL; Berry M; Kong MF; Kwiatek MA; Samsom M; Horowitz M
Diabetes Care; 1999 Feb; 22(2):339-44. PubMed ID: 10333955
[TBL] [Abstract][Full Text] [Related]
12. A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 Diabetes.
Wu T; Little TJ; Bound MJ; Borg M; Zhang X; Deacon CF; Horowitz M; Jones KL; Rayner CK
Diabetes Care; 2016 Apr; 39(4):511-7. PubMed ID: 26786576
[TBL] [Abstract][Full Text] [Related]
13. Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without type 2 diabetes.
Chowdhury S; Reeds DN; Crimmins DL; Patterson BW; Laciny E; Wang S; Tran HD; Griest TA; Rometo DA; Dunai J; Wallendorf MJ; Ladenson JH; Polonsky KS; Wice BM
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G301-9. PubMed ID: 24356886
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus.
Schirra J; Leicht P; Hildebrand P; Beglinger C; Arnold R; Göke B; Katschinski M
J Endocrinol; 1998 Jan; 156(1):177-86. PubMed ID: 9496247
[TBL] [Abstract][Full Text] [Related]
15. Erythromycin derivative improves gastric emptying and insulin requirement in diabetic patients with gastroparesis.
Ishii M; Nakamura T; Kasai F; Baba T; Takebe K
Diabetes Care; 1997 Jul; 20(7):1134-7. PubMed ID: 9203450
[TBL] [Abstract][Full Text] [Related]
16. Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes.
Vella A; Bock G; Giesler PD; Burton DB; Serra DB; Saylan ML; Dunning BE; Foley JE; Rizza RA; Camilleri M
Diabetes; 2007 May; 56(5):1475-80. PubMed ID: 17303799
[TBL] [Abstract][Full Text] [Related]
17. Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial.
Rayner CK; Watson LE; Phillips LK; Lange K; Bound MJ; Grivell J; Wu T; Jones KL; Horowitz M; Ferrannini E; Tricò D; Frascerra S; Mari A; Natali A
Diabetes Care; 2020 Aug; 43(8):1813-1821. PubMed ID: 32471908
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.
Cervera A; Wajcberg E; Sriwijitkamol A; Fernandez M; Zuo P; Triplitt C; Musi N; DeFronzo RA; Cersosimo E
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E846-52. PubMed ID: 18334612
[TBL] [Abstract][Full Text] [Related]
19. The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients.
Flint A; Kapitza C; Hindsberger C; Zdravkovic M
Adv Ther; 2011 Mar; 28(3):213-26. PubMed ID: 21340616
[TBL] [Abstract][Full Text] [Related]
20. Effects of lipase inhibition on gastric emptying of, and on the glycaemic, insulin and cardiovascular responses to, a high-fat/carbohydrate meal in type 2 diabetes.
O'Donovan D; Horowitz M; Russo A; Feinle-Bisset C; Murolo N; Gentilcore D; Wishart JM; Morris HA; Jones KL
Diabetologia; 2004 Dec; 47(12):2208-14. PubMed ID: 15662558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
